Advances in Acute Treatment of Acquired Thrombotic Thrombocytopenia Purpura
This activity will review the pathophysiology and diagnosis of TTP, with a focus on available treatments.
Reinforcing Pharmacist Confidence in Current and Emerging Dosing Strategies for Immune Checkpoint Inhibitors
This activity will review ICI dosing, as well as various dosing schemas that may be employed, particularly in the setting of COVID-19.
Hepatocellular Carcinoma: Perspectives on Disparities in Care and Managed Care Considerations in an Evolving Treatment Landscape
This discussion will highlight recently approved and emerging therapeutic options in the HCC treatment landscape and address resource utilization strategies for managed care professionals to consider when determining the most appropriate management plans for patients.
Oncology Biosimilars: The Value to Managed Care
Examine the considerations for incorporating a biosimilar into a managed care formulary